Literature DB >> 28003715

High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.

Joshua S Wooten1, Tayler N Nick1, Andrew Seija1, Kaylee E Poole1, Kelsey B Stout1.   

Abstract

BACKGROUND: Overnutrition of saturated fats and fructose is one of the major factors for the development of nonalcoholic fatty liver disease. Because omega-3 polyunsaturated fatty acids (n-3fa) have established lipid lowering properties, we tested the hypothesis that n-3fa prevents high-fat and fructose-induced fatty liver disease in mice.
METHODS: Male C57BL/6J mice were randomly assigned to one of the following diet groups for 14 weeks: normal diet (ND), high-fat lard-based diet (HFD), HFD with fructose (HFD + Fru), high-fat fish-oil diet (FOD), or FOD + Fru.
RESULTS: Despite for the development of obesity and insulin resistance, FOD had 65.3% lower (P < 0.001) hepatic triglyceride levels than HFD + Fru, which was blunted to a 38.5% difference (P = 0.173) in FOD + Fru. The lower hepatic triglyceride levels were associated with a lower expression of lipogenic genes LXRα and FASN, as well as the expression of genes associated with fatty acid uptake and triglyceride synthesis, CD36 and SCD1, respectively. Conversely, the blunted hypotriglyceride effect of FOD + Fru was associated with a higher expression of CD36 and SCD1.
CONCLUSIONS: During overnutrition, a diet rich in n-3fa may prevent the severity of hepatic steatosis; however, when juxtaposed with a diet high in fructose, the deleterious effects of overnutrition blunted the hypolipidemic effects of n-3fa.

Entities:  

Keywords:  ACC1, acetyl-CoA carboxylase-1; CPT1a, carnitine palmitoyltransferase 1a; ChREBP, carbohydrate response element binding protein; FASN, fatty acid synthase; FFA, free fatty acid; LPL, lipoprotein lipase; LXRα, liver-X-receptor; MTTP, microsomal triglyceride transfer protein; NAFLD, nonalcoholic fatty liver disease; PPARα, peroxisome proliferator activated receptor α; PPARγ, peroxisome proliferator activated receptor γ; SCD1, stearoyl-CoA desaturase 1; SREBP1c, sterol response element binding protein; T2DM, type 2 diabetes mellitus; TRL, triglyceride-rich lipoproteins; VLDL, very low-density lipoprotein; fructose; lipid metabolism; lipotoxicity; n-3fa, omega-3 polyunsaturated fatty acids; omega-3 polyunsaturated fatty acids; overnutrition

Year:  2016        PMID: 28003715      PMCID: PMC5157917          DOI: 10.1016/j.jceh.2016.09.001

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  47 in total

1.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.

Authors:  M Raabe; M M Véniant; M A Sullivan; C H Zlot; J Björkegren; L B Nielsen; J S Wong; R L Hamilton; S G Young
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.

Authors:  Bin Dong; Chin Fung Kelvin Kan; Amar B Singh; Jingwen Liu
Journal:  J Lipid Res       Date:  2013-02-20       Impact factor: 5.922

3.  Regulation of rat hepatic L-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-alpha agonist.

Authors:  Jinghua Xu; Barbara Christian; Donald B Jump
Journal:  J Biol Chem       Date:  2006-04-27       Impact factor: 5.157

4.  Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta.

Authors:  Y Zhang; J J Repa; K Gauthier; D J Mangelsdorf
Journal:  J Biol Chem       Date:  2001-09-18       Impact factor: 5.157

Review 5.  Regulation of the expression of lipogenic enzyme genes by carbohydrate.

Authors:  H C Towle; E N Kaytor; H M Shih
Journal:  Annu Rev Nutr       Date:  1997       Impact factor: 11.848

6.  Increased expression of PPARgamma in high fat diet-induced liver steatosis in mice.

Authors:  Mitsutaka Inoue; Takaaki Ohtake; Wataru Motomura; Nobuhiko Takahashi; Yayoi Hosoki; Shigeki Miyoshi; Yasuaki Suzuki; Hiroyuki Saito; Yutaka Kohgo; Toshikatsu Okumura
Journal:  Biochem Biophys Res Commun       Date:  2005-10-14       Impact factor: 3.575

Review 7.  Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.

Authors:  Martin Adiels; Sven-Olof Olofsson; Marja-Riitta Taskinen; Jan Borén
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07       Impact factor: 8.311

Review 8.  Metabolic effects of fructose and the worldwide increase in obesity.

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression.

Authors:  Jong Bae Seo; Hyang Mi Moon; Woo Sik Kim; Yun Sok Lee; Hyun Woo Jeong; Eung Jae Yoo; Jungyeob Ham; Heonjoong Kang; Myoung-Gyu Park; Knut R Steffensen; Thomas M Stulnig; Jan-Ake Gustafsson; Sang Dai Park; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 10.  Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids.

Authors:  Dimitrios G Bouzianas; Stella D Bouziana; Apostolos I Hatzitolios
Journal:  Nutr Rev       Date:  2013-10-22       Impact factor: 7.110

View more
  3 in total

1.  Protopanaxadiol and Protopanaxatriol-Type Saponins Ameliorate Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus in High-Fat Diet/Streptozocin-Induced Mice.

Authors:  Jianjun Deng; Yao Liu; Zhiguang Duan; Chenhui Zhu; Junfeng Hui; Yu Mi; Pei Ma; Xiaoxuan Ma; Daidi Fan; Haixia Yang
Journal:  Front Pharmacol       Date:  2017-08-02       Impact factor: 5.810

2.  Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy.

Authors:  Xinxu Zhang; Yuanyuan Deng; Juan Xiang; Huixia Liu; Jiani Zhang; Jie Liao; Ke Chen; Bo Liu; Jun Liu; Ying Pu
Journal:  Drug Des Devel Ther       Date:  2020-08-19       Impact factor: 4.162

3.  Blood-Brain Barrier Dysfunction Precedes Cognitive Decline and Neurodegeneration in Diabetic Insulin Resistant Mouse Model: An Implication for Causal Link.

Authors:  Ryusuke Takechi; Virginie Lam; Emily Brook; Corey Giles; Nicholas Fimognari; Armin Mooranian; Hani Al-Salami; Stephanie H Coulson; Michael Nesbit; John C L Mamo
Journal:  Front Aging Neurosci       Date:  2017-12-01       Impact factor: 5.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.